BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Pieris 

Blumenstraße 16

Freising-Weihenstephan    85354  Germany
Phone: 49-0-8161-71-389 Fax: 49-0-8161-71-3484


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Pieris Achieves Fourth Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 1/13/2014 7:53:14 AM    More...
Pieris Receives Third Milestone Payment In Daiichi Sankyo, Inc. (4568.t) Collaboration To Develop Anticalin® Therapeutics 11/12/2013 7:02:45 AM    More...
Zydus Cadila and Pieris Sign Broad Co-Development Alliance for Novel Anticalin® Therapeutics 10/16/2013 10:06:06 AM    More...
Pieris and Sanofi (France) (SAN.PA) Broaden Existing Collaboration 4/10/2013 11:37:20 AM    More...
Pieris Presents Data and Reveals Targets for Anticalin® Bispecific PRS-190 at European Antibody Congress 11/29/2012 9:46:50 AM    More...
Pieris Achieves First Milestone Payment in Daiichi Sankyo, Inc. (4568.t) Collaboration to Develop Anticalin® Therapeutics 10/9/2012 11:01:37 AM    More...
Pieris Presents Preclinical Data for PRS-110 c-Met Antagonist Anticalin® at the American Association for Cancer Research Annual Meeting 4/4/2012 9:52:40 AM    More...
Pieris Receives BMBF Grant to Fund PRS-110c-Met Antagonist Anticalin(R) Program 2/7/2012 9:56:05 AM    More...
Pieris Presents Preclinical Data for PRS-080 Hepcidin Antagonist Anticalin(R) Program at American Society of Hematology Annual Meeting 12/13/2011 10:21:31 AM    More...
Pieris Announces Results and Successful Completion of its PRS-050 Anticalin Phase I Trial at AACR-EORTC-NCI Molecular Targets and Cancer Therapeutics Conference 11/15/2011 10:53:01 AM    More...
1234

//-->